Hartford Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587K Sell
10,183
-819
-7% -$47K 0.13% 103
2026
Q1
$667K Sell
11,002
-476
-4% -$27.7K 0.17% 91
2025
Q4
$619K Sell
11,478
-2,334
-17% -$112K 0.16% 90
2025
Q3
$623K Sell
13,812
-4,221
-23% -$197K 0.17% 95
2025
Q2
$835K Sell
18,033
-1,561
-8% -$76.6K 0.23% 81
2025
Q1
$1.2M Sell
19,594
-143
-0.7% -$8.34K 0.25% 103
2024
Q4
$1.12M Sell
19,737
-1,531
-7% -$85.5K 0.23% 106
2024
Q3
$1.1M Sell
21,268
-953
-4% -$44.7K 0.22% 106
2024
Q2
$923K Sell
22,221
-8,525
-28% -$381K 0.2% 111
2024
Q1
$1.67M Sell
30,746
-9,952
-24% -$507K 0.35% 85
2023
Q4
$2.09M Sell
40,698
-746
-2% -$39.2K 0.47% 66
2023
Q3
$2.41M Sell
41,444
-439
-1% -$26.9K 0.61% 57
2023
Q2
$2.68M Buy
41,883
+1,808
+5% +$121K 0.66% 52
2023
Q1
$2.78M Sell
40,075
-249
-0.6% -$17.6K 0.72% 49
2022
Q4
$2.9M Sell
40,324
-1,844
-4% -$139K 0.77% 48
2022
Q3
$3M Sell
42,168
-4,568
-10% -$331K 0.88% 40
2022
Q2
$3.6M Sell
46,736
-2,395
-5% -$182K 1% 36
2022
Q1
$3.59M Sell
49,131
-442
-0.9% -$29.7K 0.87% 42
2021
Q4
$3.09M Buy
49,573
+136
+0.3% +$7.98K 0.72% 56
2021
Q3
$2.92M Sell
49,437
-95
-0.2% -$6.26K 0.74% 51
2021
Q2
$3.31M Buy
49,532
+16
+0% +$1.04K 0.82% 47
2021
Q1
$3.13M Buy
49,516
+60
+0.1% +$3.73K 0.78% 46
2020
Q4
$3.07M Buy
49,456
+581
+1% +$35.7K 0.81% 43
2020
Q3
$2.95M Buy
48,875
+372
+0.8% +$22.4K 0.87% 38
2020
Q2
$2.85M Sell
48,503
-1,045
-2% -$62.5K 0.91% 36
2020
Q1
$2.76M Sell
49,548
-12,497
-20% -$764K 1.1% 29
2019
Q4
$3.98M Buy
62,045
+109
+0.2% +$6.24K 1.24% 21
2019
Q3
$3.14M Sell
61,936
-3,034
-5% -$143K 1.05% 28
2019
Q2
$2.95M Sell
64,970
-1,139
-2% -$53.1K 0.98% 31
2019
Q1
$3.15M Buy
66,109
+941
+1% +$46.9K 1.08% 28
2018
Q4
$3.39M Sell
65,168
-2,119
-3% -$114K 1.29% 22
2018
Q3
$4.18M Sell
67,287
-1,045
-2% -$62K 1.41% 17
2018
Q2
$3.78M Sell
68,332
-588
-0.9% -$31.8K 1.35% 18
2018
Q1
$4.36M Sell
68,920
-163
-0.2% -$10.5K 2.21% 9
2017
Q4
$4.23M Buy
69,083
+21
+0% +$1.31K 2.08% 8
2017
Q3
$4.4M Sell
69,062
-92
-0.1% -$5.37K 2.23% 7
2017
Q2
$3.85M Sell
69,154
-93
-0.1% -$5.06K 1.73% 14
2017
Q1
$3.77M Buy
69,247
+1,223
+2% +$67.1K 2.27% 9
2016
Q4
$3.98M Sell
68,024
-1,056
-2% -$57.7K 2.36% 9
2016
Q3
$3.72M Sell
69,080
-833
-1% -$53.5K 2.26% 7
2016
Q2
$5.14M Sell
69,913
-394
-0.6% -$27.8K 3.09% 3
2016
Q1
$4.49M Buy
70,307
+1,506
+2% +$95K 2.79% 3
2015
Q4
$4.73M Buy
68,801
+197
+0.3% +$13K 2.95% 3
2015
Q3
$4.06M Buy
68,604
+6
+0% +$381 2.71% 3
2015
Q2
$4.56M Sell
68,598
-1,234
-2% -$81.3K 2.67% 4
2015
Q1
$4.5M Buy
69,832
+86
+0.1% +$5.38K 2.77% 4
2014
Q4
$4.12M Buy
69,746
+256
+0.4% +$14.4K 2.54% 4
2014
Q3
$3.56M Buy
69,490
+305
+0.4% +$15.2K 2.13% 6
2014
Q2
$3.36M Buy
69,185
+480
+0.7% +$23.7K 2.03% 6
2014
Q1
$3.57M Buy
68,705
+555
+0.8% +$29.5K 2.33% 4
2013
Q4
$3.62M Sell
68,150
-195
-0.3% -$9.93K 2.35% 4
2013
Q3
$3.16M Sell
68,345
-193
-0.3% -$8.47K 2.18% 7
2013
Q2
$3.06M Buy
+68,538
New +$2.98M 2.12% 8

Other funds holding BMY

Hartford Financial Management's BMY Position: Q2 2026 in Review

Hartford Financial Management reduced its Bristol-Myers Squibb (BMY) stake by 7.4% in Q2 2026, selling an estimated $47K and leaving 10,183 shares worth $587K. The position accounts for 0.13% of the portfolio, ranked #103.

Hartford Financial Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.14M in Q2 2016. 942 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hartford Financial Management held 10,183 shares of Bristol-Myers Squibb worth $587K as of Q2 2026.
  • Hartford Financial Management sold 819 Bristol-Myers Squibb shares in Q2 2026, an estimated $47K.
  • Bristol-Myers Squibb made up 0.13% of Hartford Financial Management's portfolio in Q2 2026, its #103 holding.
  • Hartford Financial Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Hartford Financial Management's Bristol-Myers Squibb position peaked at $5.14M in Q2 2016.
  • 942 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.